We determined that its inhibition of MDR was mediated through the Cox-2/PKC-α/P-gp pathway, which provides a crucial theoretical basis concerning the molecular mechanisms of gastric cancer therapy. This evidence concerns the gene PTGS2 and gastric cancer.